The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model
Background: A protease/antiprotease disbalance is observed in inflammatory bowel diseases (IBD). We therefore studied the effect of the novel serine protease inhibitor UAMC-00050 on intestinal inflammation and permeability in a chronic colitis T cell transfer mouse model to get further insight into...
Main Authors: | Hanne Van Spaendonk, Hannah Ceuleers, Annemieke Smet, Maya Berg, Jurgen Joossens, Pieter Van der Veken, Sven M. Francque, Anne-Marie Lambeir, Joris G. De Man, Ingrid De Meester, Koen Augustyns, Benedicte Y. De Winter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.682065/full |
Similar Items
-
The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult
by: Hannah Ceuleers, et al.
Published: (2022-06-01) -
Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats
by: Nikita Hanning, et al.
Published: (2021-05-01) -
The effect of pharmacological inhibition of Serine Proteases on neuronal networks in vitro
by: Sebastiaan Van De Vijver, et al.
Published: (2019-04-01) -
Selective Activity-Based Probes Targeting Fibroblast Activation Protein (FAP)
by: Johannes Vrijdag, et al.
Published: (2019-08-01) -
Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteases
by: Alba Ramos-Llorca, et al.
Published: (2023-01-01)